Amphastar Pharmaceuticals Inc (AMPH)
48.02
+0.14
(+0.29%)
USD |
NASDAQ |
Sep 27, 16:00
47.98
-0.04
(-0.08%)
After-Hours: 20:00
Amphastar Pharmaceuticals Cash from Operations (Quarterly): 69.11M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 69.11M |
| March 31, 2024 | 55.29M |
| December 31, 2023 | 23.86M |
| September 30, 2023 | 64.33M |
| June 30, 2023 | 54.92M |
| March 31, 2023 | 40.38M |
| December 31, 2022 | 15.23M |
| September 30, 2022 | 20.38M |
| June 30, 2022 | 2.815M |
| March 31, 2022 | 50.76M |
| December 31, 2021 | 40.44M |
| September 30, 2021 | 2.569M |
| June 30, 2021 | 32.16M |
| March 31, 2021 | 22.82M |
| December 31, 2020 | 16.89M |
| September 30, 2020 | 8.807M |
| June 30, 2020 | 30.09M |
| March 31, 2020 | 1.477M |
| December 31, 2019 | 5.652M |
| September 30, 2019 | -12.00M |
| June 30, 2019 | 51.72M |
| March 31, 2019 | -3.61M |
| December 31, 2018 | 9.517M |
| Date | Value |
|---|---|
| September 30, 2018 | 15.78M |
| June 30, 2018 | 4.533M |
| March 31, 2018 | 8.36M |
| December 31, 2017 | 9.765M |
| September 30, 2017 | 2.472M |
| June 30, 2017 | 4.574M |
| March 31, 2017 | 22.40M |
| December 31, 2016 | 14.01M |
| September 30, 2016 | 1.298M |
| June 30, 2016 | 9.326M |
| March 31, 2016 | 13.93M |
| December 31, 2015 | 3.287M |
| September 30, 2015 | 3.553M |
| June 30, 2015 | 2.503M |
| March 31, 2015 | 1.338M |
| December 31, 2014 | 12.32M |
| September 30, 2014 | 13.63M |
| June 30, 2014 | 0.934M |
| March 31, 2014 | -5.835M |
| December 31, 2013 | 8.512M |
| September 30, 2013 | 0.709M |
| June 30, 2013 | 20.29M |
| March 31, 2013 | 1.527M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-12.00M
Minimum
Sep 2019
69.11M
Maximum
Jun 2024
27.30M
Average
23.34M
Median
Cash from Operations (Quarterly) Benchmarks
| Omeros Corp | -45.98M |
| Harrow Inc | -2.746M |
| PetIQ Inc | 57.88M |
| Amneal Pharmaceuticals Inc | 39.66M |
| Alector Inc | -62.80M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -69.90M |
| Cash from Financing (Quarterly) | -10.72M |
| Free Cash Flow | 178.13M |
| Free Cash Flow Per Share (Quarterly) | 1.212 |
| Free Cash Flow to Equity (Quarterly) | 70.40M |
| Free Cash Flow to Firm (Quarterly) | 67.05M |
| Free Cash Flow Yield | 7.00% |